UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis

Antimicrobial agents and chemotherapy, 2021-04, Vol.95 (5)

2021

Volltextzugriff (PDF)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Nature communications, 2013-12, Vol.4 (1), Article 2907

2013

Volltextzugriff (PDF)

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis

Molecules (Basel, Switzerland), 2022-04, Vol.27 (9), p.2844

2022

Volltextzugriff (PDF)

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Journal of medicinal chemistry, 2013-05, Vol.56 (10), p.4093-4103

2013

Volltextzugriff (PDF)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis

Nature communications, 2023-11, Vol.14 (1), p.7427-7427, Article 7427

2023

Volltextzugriff (PDF)

Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis

Journal of antimicrobial chemotherapy, 2012-02, Vol.67 (2), p.415-421

2012

Volltextzugriff (PDF)

Risk of Tuberculosis Reactivation With Tofacitinib (CP-690550)

The Journal of infectious diseases, 2012-06, Vol.205 (11), p.1705-1708

2012

Volltextzugriff (PDF)

Characterization of a Novel Cell Wall-anchored Protein with Carboxylesterase Activity Required for Virulence in Mycobacterium tuberculosis

The Journal of biological chemistry, 2007-06, Vol.282 (25), p.18348-18356

2007

Volltextzugriff (PDF)

Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in Mice

mBio, 2023-04, Vol.14 (2), p.e0349622-e0349622

2023

Volltextzugriff (PDF)

Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model

PloS one, 2012-02, Vol.7 (2), p.e30749-e30749

2012

Volltextzugriff (PDF)

Pharmacokinetic and In Vivo Efficacy Studies of the Mycobactin Biosynthesis Inhibitor Salicyl-AMS in Mice

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.5138-5140

2013

Volltextzugriff (PDF)

MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival

JCI insight, 2023-10, Vol.8 (20)

2023

Volltextzugriff (PDF)

The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides

PLoS pathogens, 2009-07, Vol.5 (7), p.e1000534-e1000534

2009

Volltextzugriff (PDF)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis

Nature communications, 2012-03, Vol.3 (1), p.753-753, Article 753

2012

Volltextzugriff (PDF)

Rv2190c, an NlpC/P60 family protein, is required for full virulence of Mycobacterium tuberculosis

PloS one, 2012-08, Vol.7 (8), p.e43429-e43429

2012

Volltextzugriff (PDF)

Extrapulmonary Dissemination of Mycobacterium bovis but Not Mycobacterium tuberculosis in a Bronchoscopic Rabbit Model of Cavitary Tuberculosis

Infection and Immunity, 2009-02, Vol.77 (2), p.598-603

2009

Volltextzugriff (PDF)

Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactams

mBio, 2014-09, Vol.5 (5), p.e01767-e01714

2014

Volltextzugriff (PDF)

Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem, 2011-02, Vol.6 (2), p.334-342

2011

Volltextzugriff (PDF)

Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery

Journal of antimicrobial chemotherapy, 2010-11, Vol.65 (11), p.2347-2358

2010

Volltextzugriff (PDF)

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis

EBioMedicine, 2015-08, Vol.2 (8), p.868-873

2015

Volltextzugriff (PDF)

Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen

The Journal of Microbiology, 2013, 51(5), , pp.651-658

2013

Volltextzugriff (PDF)

Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6232-6247

2016

Volltextzugriff (PDF)

The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models

PloS one, 2010-04, Vol.5 (4), p.e10289

2010

Volltextzugriff (PDF)

Transfer of immunoglobulins through the mammary endothelium and epithelium and in the local lymph node of cows during the initial response after intramammary challenge with E. coli endotoxin

Acta veterinaria scandinavica, 2008-07, Vol.50 (1), p.26-26, Article 26

2008

Volltextzugriff (PDF)

Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis

Journal of medicinal chemistry, 2018-02, Vol.61 (3), p.791-803

2018

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(55)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(39)
Animals
(28)
Tuberculosis
(25)
Mycobacterium Tuberculosis
(22)
Mice
(21)
Microbiology
(21)
Mycobacterium Tuberculosis - Drug Effects
(19)
Pharmacology & Pharmacy
(19)
Antitubercular Agents - Pharmacology
(16)
Mice, Inbred Balb C
(14)
Microbial Sensitivity Tests
(13)
Chemistry, Medicinal
(12)
Female
(12)
Bacterial Proteins - Metabolism
(9)
Disease Models, Animal
(9)
Humans
(9)
Biological And Medical Sciences
(8)
Drug Design
(8)
Drug Resistance
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis

Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis

Risk of Tuberculosis Reactivation With Tofacitinib (CP-690550)

Characterization of a Novel Cell Wall-anchored Protein with Carboxylesterase Activity Required for Virulence in Mycobacterium tuberculosis

Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in Mice

Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model

Pharmacokinetic and In Vivo Efficacy Studies of the Mycobactin Biosynthesis Inhibitor Salicyl-AMS in Mice

MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival

The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis

Rv2190c, an NlpC/P60 family protein, is required for full virulence of Mycobacterium tuberculosis

Extrapulmonary Dissemination of Mycobacterium bovis but Not Mycobacterium tuberculosis in a Bronchoscopic Rabbit Model of Cavitary Tuberculosis

Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactams

Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis

Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen

Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection

The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models

Transfer of immunoglobulins through the mammary endothelium and epithelium and in the local lymph node of cows during the initial response after intramammary challenge with E. coli endotoxin

Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis

Suchergebnisse filtern